Reference Materials

Shop By
View as List Grid

3 Items

Set Descending Direction
  1. Chloramphenicol, Agonist of TAS2R41;Agonist of TAS2R8
    Cas#: 56-75-7        Compound CID:  5959
    Formula:  C11H12Cl2N2O5        Molecular Weight: 323.13
    IUPAC Name: 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide
    SMILES: C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
    InChIKey: WIIZWVCIJKGZOK-RKDXNWHRSA-N
    InChI: InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1
    Synonyms: Chloramex | Laevomycetinum | Chloramfilin | Chloramsaar | Chlornitromycin | Ertilen | Chloramficin | Chloro-25 vetag ...
  2. Oleic acid, Agonist of FFA1 receptor;Agonist of FFA4 receptor;Activator of PLD2
    Cas#: 112-80-1        Compound CID:  445639
    Formula:  CH3(CH2)7CH=CH(CH2)7COOH        Molecular Weight: 282.46
    IUPAC Name: (Z)-octadec-9-enoic acid
    SMILES: CCCCCCCCC=CCCCCCCCC(=O)O
    InChIKey: ZQPPMHVWECSIRJ-KTKRTIGZSA-N
    InChI: InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-
    Synonyms: C18:1 | HSDB 1240 | Elainic acid | Pamolyn | Priolene 6936 | K 52 | Emersol 220 white oleic acid | OLEICACID | UNII-2...
  3. Progesterone solution, Progesterone receptor agonist
    Cas#: 57-83-0        Compound CID:  5994
    Formula:  C21H30O2        Molecular Weight: 314.47
    IUPAC Name: (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
    SMILES: CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
    InChIKey: RJKFOVLPORLFTN-LEKSSAKUSA-N
    InChI: InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1
    Synonyms: Luteodyn | Progestron | Cyclogesterin | Hormoluton | Lucorteum | Utrogest | Gynolutone | Progesteronum [INN-Latin] | ...
per page

We noticed your location and want to make sure you’re viewing the most relevant version of our site.
Would you like to be redirected to your local region’s page for a smoother experience?